Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

LeMaitre Vascular, Inc. - Common Stock (NQ: LMAT )

90.29 +0.75 (+0.84%)
Streaming Delayed Price Updated: 10:22 AM EDT, Apr 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 11,219
Open 89.50
Bid (Size) 89.82 (1)
Ask (Size) 90.88 (1)
Prev. Close 89.54
Today's Range 89.50 - 90.62
52wk Range 62.49 - 109.58
Shares Outstanding 22,263,235
Dividend Yield 0.89%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Q4 Earnings Highlights: LeMaitre (NASDAQ:LMAT) Vs The Rest Of The Surgical Equipment & Consumables - Specialty Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at LeMaitre (NASDAQ:LMAT) and the best and... 
Via StockStory
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Supply Chain
3 Healthcare Stocks Facing Headwinds
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19,... 
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities

Performance

YTD
-1.29%
-1.29%
1 Month
+4.90%
+4.90%
3 Month
-7.87%
-7.87%
6 Month
+3.82%
+3.82%
1 Year
+40.57%
+40.57%

More News

Read More
Spotting Winners: Teleflex (NYSE:TFX) And Surgical Equipment & Consumables - Specialty Stocks In Q4
Via StockStory
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Supply Chain
Earnings Scheduled For February 27, 2025
Via Benzinga
Novocure Stock Earns 96 RS Rating
Via Investor's Business Daily
In-Depth Examination Of 4 Analyst Recommendations For LeMaitre Vascular
Via Benzinga
Analyst Scoreboard: 4 Ratings For LeMaitre Vascular
Via Benzinga
Why LEMAITRE VASCULAR INC (NASDAQ:LMAT) qualifies as a quality stock.
Via Chartmill
2 Reasons to Avoid LMAT and 1 Stock to Buy Instead
Via StockStory
Topics Stocks Supply Chain
Exposures Supply Chain US Equities
Winners And Losers Of Q4: Integra LifeSciences (NASDAQ:IART) Vs The Rest Of The Surgical Equipment & Consumables - Specialty Stocks
Via StockStory
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Supply Chain
Q4 Earnings Review: Surgical Equipment & Consumables - Specialty Stocks Led by Intuitive Surgical (NASDAQ:ISRG)
Via StockStory
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Supply Chain
Navigating 4 Analyst Ratings For LeMaitre Vascular
Via Benzinga
LeMaitre (NASDAQ:LMAT) Misses Q4 Sales Targets, Stock Drops 11%
Via StockStory
What To Expect From LeMaitre’s (LMAT) Q4 Earnings
Via StockStory
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Inari Medical Stock Gets RS Rating Upgrade
Via Investor's Business Daily
ResMed Is 80 And 80: Hits 80-Plus Relative Strength Rating After Rising 80% In A Year
Via Investor's Business Daily
Apple To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Friday
Via Benzinga
This Synopsys Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Via Benzinga
LMAT Stock Earnings: LeMaitre Vascular Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Staar Surgical Stock Earns RS Rating Upgrade
Via Investor's Business Daily
Stryker Stock Sees RS Rating Treks Higher To 71
Via Investor's Business Daily
Sell In May And Go Away? – April Dividend Income Report
Via Talk Markets
LMAT Stock Earnings: LeMaitre Vascular Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Inspire Medical Systems Stock Sees IBD RS Rating Rise To 78
Via Investor's Business Daily
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.